Clinical trial · Observational
Metabolic and Immunological Phenotyping in Patients With Cancer
NCT04285242CI-TRIAL-00073556MIPPaCunknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
An observational study to investigate cachexia in participants with non-haematological cancer.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Non-Hematologic Malignancy | Non-Hematologic Malignancy | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Observational assessments | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- label
- Participants with Cancer - Group A
- description
- Assessments and observations for up to 40 days with one overnight hospital stay.
- interventionNames
- Other: Observational assessments
- label
- Healthy Volunteers - Group A
- description
- Assessments and observations for up to 2 days with one overnight hospital stay.
- interventionNames
- Other: Observational assessments
- label
- Healthy Volunteers - Group B
- description
- Assessments and observations for up to 2 days.
- interventionNames
- Other: Observational assessments
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Have given written informed consent to participate * Be aged 18 years or over at the time of signing the informed consent form * Have a histological or cytological diagnosis of a non-haematological cancer * Are willing and able to comply with study procedures and visits Exclusion Criteria: * Active infection, as determined by the investigator based on clinical symptoms and / or fever and / or requirement for antibiotics * Current treatment with chemotherapy, oral steroids or other immunosuppressive drugs (within 7 days of baseline investigations or during the study phase) * Significant acute, chronic or psychiatric condition or laboratory abnormality which in the judgment of the investigator would place the patient at undue risk or interfere with the study. * Intolerance to dairy products * Women, who are pregnant, plan to become pregnant or are lactating
References
Publications (0)
Data not yet available
No reference posted for this study.